Literature DB >> 15922328

Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase.

Hui Yang1, Teresa Burke, Jack Dempsey, Bruce Diaz, Elizabeth Collins, John Toth, Richard Beckmann, Xiang Ye.   

Abstract

We investigated why treatment of cells with dual aurora A and B kinase inhibitors produces phenotypes identical to inactivation of aurora B. We found that dual aurora kinase inhibitors in fact potently inhibit cellular activities of both kinases, indicating that inactivation of aurora B bypasses aurora A in mitosis. RNAi experiments further established that inactivation of aurora B indeed bypasses the requirement for aurora A and leads to polyploidy. Inactivation of aurora A activates checkpoint kinase BubR1 in an aurora B-dependent manner. Our results thus show that aurora B is responsible for mitotic arrest in the absence of aurora A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922328     DOI: 10.1016/j.febslet.2005.04.080

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

Review 1.  Tubulin-associated proteins: Aurora and Polo-like kinases as therapeutic targets in cancer.

Authors:  Steven L Warner; Bret J Stephens; Daniel D Von Hoff
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

Review 2.  Target validation and biomarker identification in oncology : the example of aurora kinases.

Authors:  Riccardo Colombo; Jürgen Moll
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

3.  Ubiquitin-specific cysteine protease 2a (USP2a) regulates the stability of Aurora-A.

Authors:  Yan Shi; Larry R Solomon; Ana Pereda-Lopez; Vincent L Giranda; Yan Luo; Eric F Johnson; Alexander R Shoemaker; Joel Leverson; Xuesong Liu
Journal:  J Biol Chem       Date:  2011-09-02       Impact factor: 5.157

4.  Cdk1 activity is required for mitotic activation of aurora A during G2/M transition of human cells.

Authors:  Robert D Van Horn; Shaoyou Chu; Li Fan; Tinggui Yin; Jian Du; Richard Beckmann; Mary Mader; Guoxin Zhu; John Toth; Kerry Blanchard; Xiang S Ye
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

5.  Aurora kinase B/C inhibition impairs malignant glioma growth in vivo.

Authors:  Roberto Jose Diaz; Brian Golbourn; Maryam Shekarforoush; Christian A Smith; James T Rutka
Journal:  J Neurooncol       Date:  2012-03-01       Impact factor: 4.130

6.  Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine Core.

Authors:  Tao Yu; Jayaram R Tagat; Angela D Kerekes; Ronald J Doll; Yonglian Zhang; Yushi Xiao; Sara Esposite; David B Belanger; Patrick J Curran; Amit K Mandal; M Arshad Siddiqui; Neng-Yang Shih; Andrea D Basso; Ming Liu; Kimberly Gray; Seema Tevar; Jennifer Jones; Suining Lee; Lianzhu Liang; Samad Ponery; Elizabeth B Smith; Alan Hruza; Johannes Voigt; Lata Ramanathan; Winifred Prosise; Mengwei Hu
Journal:  ACS Med Chem Lett       Date:  2010-06-07       Impact factor: 4.345

7.  Aurora-A kinase is essential for bipolar spindle formation and early development.

Authors:  Dale O Cowley; Jaime A Rivera-Pérez; Mark Schliekelman; Yizhou Joseph He; Trudy G Oliver; Lucy Lu; Ryan O'Quinn; E D Salmon; Terry Magnuson; Terry Van Dyke
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

8.  Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen.

Authors:  John McLaughlin; Vadim Markovtsov; Hui Li; Steve Wong; Marina Gelman; Yanhong Zhu; Christian Franci; D Wayne Lang; Erlina Pali; Joe Lasaga; Caroline Low; Feifei Zhao; Betty Chang; Tarikere L Gururaja; Weiduan Xu; Muhammad Baluom; David Sweeny; David Carroll; Arvinder Sran; Sambaiah Thota; Manjeet Parmer; Angela Romane; George Clemens; Elliott Grossbard; Kunbin Qu; Yonchu Jenkins; Taisei Kinoshita; Vanessa Taylor; Sacha J Holland; Ankush Argade; Rajinder Singh; Polly Pine; Donald G Payan; Yasumichi Hitoshi
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

9.  Aurora B is required for mitotic chromatin-induced phosphorylation of Op18/Stathmin.

Authors:  Bedrick B Gadea; Joan V Ruderman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

10.  Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression.

Authors:  Xuesong Liu; Yan Shi; Keith W Woods; Paul Hessler; Paul Kroeger; Julie Wilsbacher; Jieyi Wang; Jean Y Wang; Chunying Li; Qun Li; Saul H Rosenberg; Vincent L Giranda; Yan Luo
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.